The table below shows Dare Bioscience, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$9.89M
$5.47M
-$38.86M
-$18.09M
-$28.76M
-$25.23M
Capital expenditure
$385.28K
$573.05K
$629.43K
$63.07K
$14.52K
$17.63K
Investing cash flow
-$385.28K
-$573.05K
-$629.43K
-$63.07K
-$14.52K
-$17.63K
Dividends paid
-
-
-
-
DARE operating cash flow (10-K history)
Dare Bioscience, Inc. reported operating cash flow of -$9.89M for fiscal year 2025. That is down 280.6% from $5.47M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$2.54M (FY 2017) to -$9.89M. Figures come from the company's audited annual reports as filed with the SEC.